tiprankstipranks
Trending News
More News >
Enlivex to Present Allocetra™ Insights at OARSI 2025
PremiumCompany AnnouncementsEnlivex to Present Allocetra™ Insights at OARSI 2025
2M ago
Enlivex Completes Phase II Enrollment for Osteoarthritis Trial
Premium
Company Announcements
Enlivex Completes Phase II Enrollment for Osteoarthritis Trial
3M ago
Enlivex completed enrollment of patients in Phase II trial of Allocetra
Premium
The Fly
Enlivex completed enrollment of patients in Phase II trial of Allocetra
3M ago
Enlivex Secures Chinese Patent Allowance for Osteoarthritis Treatment
PremiumCompany AnnouncementsEnlivex Secures Chinese Patent Allowance for Osteoarthritis Treatment
4M ago
Enlivex Therapeutics receives notice of allowance for Chinese patent
Premium
The Fly
Enlivex Therapeutics receives notice of allowance for Chinese patent
4M ago
Enlivex Reports Promising Interim Results in Osteoarthritis Trial
Premium
Company Announcements
Enlivex Reports Promising Interim Results in Osteoarthritis Trial
4M ago
Enlivex Therapeutics Starts Phase II Allocetra Trail to Treat Knee Osteoarthritis
PremiumMarket NewsEnlivex Therapeutics Starts Phase II Allocetra Trail to Treat Knee Osteoarthritis
5M ago
Enlivex Wins Key Patent in Japan for Osteoarthritis Treatment
Premium
Market News
Enlivex Wins Key Patent in Japan for Osteoarthritis Treatment
5M ago
Enlivex Therapeutics (NASDAQ:ENLV) Hails Positive Trial Results for Allocetra Treatment of Knee Osteoarthritis
Premium
Market News
Enlivex Therapeutics (NASDAQ:ENLV) Hails Positive Trial Results for Allocetra Treatment of Knee Osteoarthritis
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100